The Food and Drug Administration conducted an inspection at Parametrics Medical, LLC in Leander on April 2, focusing on human cellular, tissue, and gene therapies, according to data posted on the FDA’s website.
The final report stated that Parametrics Medical, LLC was not required to make any corrections to its management processes.
The FDA regularly inspects facilities nationwide to verify whether workplaces and their products comply with FDA-regulated laws and regulations that aim to protect public health. Inspection findings are made available to the public.
According to its website, the FDA is a federal agency responsible for overseeing the safety and quality of human and animal drugs, biological products, medical supplies, and tobacco products.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
